| 化合物 | CAT 编号 | CAS 编号 | 类别 | 操作 |
|---|---|---|---|---|
| Lorazepam Related Compound A | CS-EB-03210 | 2848-96-6 | USP Standards | |
| Lorazepam Related Compound A | CS-IP-00092 | 2848-96-6 | IP Standards | |
| Lorazepam Related Compound A(Secondary Standards traceble to USP) | CS-ER-01214 | 2848-96-6 | Secondary Standards | |
| Lorazepam Related Compound B | CS-EB-03211 | 2958-36-3 | USP Standards | |
| Lorazepam Related Compound B | CS-IP-00093 | 2958-36-3 | IP Standards | |
| Lorazepam Related Compound B(Secondary Standards traceble to USP) | CS-ER-01215 | 2958-36-3 | Secondary Standards | |
| Lorazepam Related Compound C | CS-IP-00094 | 93955-15-8 | IP Standards | |
| Lorazepam Related Compound C | CS-T-11370 | 93955-15-8 | Impurity | |
| Lorazepam Related Compound C (1370349) | CS-EB-02874 | 93955-15-8 | USP Standards | |
| Lorazepam Related Compound D | CS-IP-00095 | 54643-79-7 | IP Standards | |
| Lorazepam Related Compound D | CS-T-50584 | 54643-79-7 | Impurity | |
| Lorazepam Related Compound D (J0L024) | CS-EB-01224 | 54643-79-7 | USP Standards | |
| Lorazepam Related Compound D(Secondary Standards traceble to USP) | CS-ER-01216 | 54643-79-7 | Secondary Standards | |
| Lorazepam related Compound E | CS-IP-00096 | 773871-49-1 | IP Standards | |
| Lorazepam Related Compound E | CS-Y-00065 | 773871-49-1 | Impurity | |
| Lorazepam Related Compound E (J0K256) | CS-EB-01225 | 773871-49-1 | USP Standards | |
| Lorazepam Related Compound E(Secondary Standards traceble to USP) | CS-ER-01220 | 773871-49-1 | Secondary Standards | |
| Lormetazepam | CS-EK-00589 | 848-75-9 | API | |
| Lormetazepam-13C,d3 | CS-T-102425 | 1285932-00-4 | Stable Isotopes | |
| L-Phenylacetyl Carbinol | CS-T-60345 | 53439-91-1 | Intermediate | |
| L-threo-methylphenidate | CS-O-65627 | 40431-62-7 | Impurity | |
| L-threo-Methylphenidate Hydrochloride | CS-TB-96516 | 29419-95-2 | Chiral | |
| Lysergide | CS-TB-78062 | 50-37-3 | API | |
| Lysergide D3 | CS-T-56965 | 136765-38-3 | Stable Isotopes |
产品已添加到您的 RFQ 购物篮。
产品已添加到您的 RFQ 购物篮。